Plasma neurofilament light chain levels in patients with MS switching from injectable therapies to fingolimod

Piehl, F; Kockum, I; Khademi, M; Blennow, K; Lycke, J; Zetterberg, H; Olsson, T; (2018) Plasma neurofilament light chain levels in patients with MS switching from injectable therapies to fingolimod. Multiple Sclerosis Journal , 24 (8) pp. 1046-1054. 10.1177/1352458517715132 . Green open access

http://bit.ly/2FLIpIJ